Top compounds associated with response to CENPO


Feature Type Standardized
Nominal ANOVA
mRNA B02 CTRPv2 pan-cancer AAC 0.085 0.02
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.081 0.02
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.087 0.02
mRNA WZ4002 CTRPv2 pan-cancer AAC -0.1 0.03
mRNA NSC-87877 GDSC1000 pan-cancer AAC -0.077 0.03
mRNA SNX-2112:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.075 0.03
mRNA GSK429286A GDSC1000 pan-cancer AAC 0.071 0.03
mRNA paclitaxel CTRPv2 pan-cancer AAC 0.075 0.03
mRNA BRD-K35604418 CTRPv2 pan-cancer AAC 0.084 0.03
mRNA DMOG GDSC1000 pan-cancer AAC -0.07 0.03
Download CSV